Microbiome Forum: Europe

Conference Synopsis The Microbiome Community An overview of the human microbiome project Monitoring and regulating microbial communities Ethics, legal and social implications in microbiome research Diversity, stability and resilience of the microbiome Building a translation microbiome program Can we characterise the ‘normal’ microbiome? The human virome & its applications in health and disease Sequencing and bioinformatics of the human microbiome Bioinformatics and large data management, data storage and how we use the data we have collected Metagenomic and post-metagenomic approaches to microbiome research Venture Capital, Collaboration, Investment and Commercialisation Venture capital investment opportunities Commercialising the microbiome: Developing business relationships between academic research, pharma and business ventures Collaboration partnerships – the global scope of microbiome research/structuring successful collaborations Bringing live microbial products to market – IP and regulation Pharmaceutical involvement and investment Small company showcase The Human Microbiome in Health and Disease Antibiotic Exposure: Contemplating novel antibiotic therapies that do not destroy the healthy microbiome Case studies: The microbiome and its role in IBD, cancer, obesity, immunity, diabetes and cancer Studies in the GI tract & intestinal epithelium Microbiome transplantation/fecal transplantation Examining bacteriophage therapy for patients worldwide Research and Development outside the Gut How does age affect the microbiome – young and elderly microbiome Skin microbiome – acne, eczema, atopic dermatitis, probiotics, wound health Microbiome and cosmetic applications Oral microbiome and vaginal microbiome in health and disease Commercialising therapies for respiratory disease from lung microbiome research Latest developments on gut-brain axis and behaviour Microbiome and the Food World Developing nutritional products utilising microbiome research Can disease be controlled via diet Probiotics, prebiotics and pharmaceuticals Probiotics and the public – mobilising dietary supplements within economic markets Click Here for the full agenda. To receive agenda updates and news about developments in research, you canjoin our Microbiome newsletter group, also feel free to contact us with any suggestions or requests: Alex White, Conference Producer Tel:  +44 (0) 1865 849841 alex@globalengage.co.uk